M&A Deal Summary

DUSA Pharmaceuticals Acquires Sirius Laboratories

On March 10, 2006, DUSA Pharmaceuticals acquired healthcare services company Sirius Laboratories

Acquisition Highlights
  • This is DUSA Pharmaceuticals’ 1st transaction in the Healthcare Services sector.
  • This is DUSA Pharmaceuticals’ 1st transaction in the United States.
  • This is DUSA Pharmaceuticals’ 1st transaction in Illinois.

M&A Deal Summary

Date 2006-03-10
Target Sirius Laboratories
Sector Healthcare Services
Buyer(s) DUSA Pharmaceuticals
Deal Type Add-on Acquisition

Target

Sirius Laboratories

Vernon Hills, Illinois, United States
Sirius Laboratories, Inc. is a dermatology specialty pharmaceutical company.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DUSA Pharmaceuticals

Wilmington, Massachusetts, United States

Category Company
Founded 1991
Sector Medical Products
Employees99
DESCRIPTION

DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2006 M&A 1 of 1